Context Therapeutics Inc. (CNTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
2001 Market Street
Philadelphia, PA 19103
United States of America (the)
Phone
267 225 7416
Sector
Healthcare
Industry
Biotechnology
Employees
15
First IPO Date
October 20, 2021
| Name | Title | Pay | Year Born |
| Martin A. Lehr | Co-Founder, President, Chief Executive Officer & Director | 914,015 | 1984 |
| Karen Chagin | Chief Medical Officer | 26,610 | 1977 |
| Alex C. Levit | Chief Legal Officer & Corporate Secretary | 576,307 | 1979 |
| Jennifer Minai-Azary | Chief Financial Officer & Treasurer | 610,731 | 1978 |
| Christopher Beck | Senior Vice President of Operations | 0 | N/A |
| Jeffrey Liebman | Associate Director of Accounting | 0 | N/A |
| Jennifer Dashnau | Senior Vice President of Technical Operations | 0 | N/A |
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.